Satoshi Okuno

654 total citations
34 papers, 484 citations indexed

About

Satoshi Okuno is a scholar working on Molecular Biology, Oncology and Dermatology. According to data from OpenAlex, Satoshi Okuno has authored 34 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Dermatology. Recurrent topics in Satoshi Okuno's work include Dermatology and Skin Diseases (5 papers), Cancer therapeutics and mechanisms (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Satoshi Okuno is often cited by papers focused on Dermatology and Skin Diseases (5 papers), Cancer therapeutics and mechanisms (5 papers) and Nanoparticle-Based Drug Delivery (4 papers). Satoshi Okuno collaborates with scholars based in Japan, United States and Belgium. Satoshi Okuno's co-authors include Toshiro Yano, Mitsunori Harada, Hiroshi Hamana, Hiroyuki Sakakibara, Yuichi Sugiyama, T. Yano, Kokichi Suzuki, Jun Imai, Takehiko Suzuki and Hiroshi Watanabe and has published in prestigious journals such as Clinical Cancer Research, Journal of Controlled Release and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Satoshi Okuno

30 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Okuno Japan 12 265 173 101 73 59 34 484
Yifeng Pan China 14 327 1.2× 254 1.5× 99 1.0× 151 2.1× 69 1.2× 23 776
Céline Bouclier France 11 258 1.0× 93 0.5× 91 0.9× 64 0.9× 106 1.8× 14 512
Prajna Mishra India 12 368 1.4× 167 1.0× 158 1.6× 130 1.8× 41 0.7× 14 697
Hossein Zarei Jaliani Iran 13 261 1.0× 122 0.7× 75 0.7× 95 1.3× 28 0.5× 35 533
Ravi Prakash Shukla India 14 255 1.0× 200 1.2× 86 0.9× 198 2.7× 41 0.7× 39 613
Aiswarya Chaudhuri India 15 313 1.2× 167 1.0× 72 0.7× 140 1.9× 39 0.7× 28 626
Martina Tilio Italy 9 288 1.1× 127 0.7× 96 1.0× 84 1.2× 66 1.1× 9 528
Mohsen Alipour Iran 16 392 1.5× 183 1.1× 77 0.8× 151 2.1× 36 0.6× 30 759
Hoda Soleymani Abyaneh Canada 10 225 0.8× 148 0.9× 109 1.1× 158 2.2× 66 1.1× 12 492
Beom Suk Lee South Korea 14 273 1.0× 272 1.6× 56 0.6× 246 3.4× 66 1.1× 21 651

Countries citing papers authored by Satoshi Okuno

Since Specialization
Citations

This map shows the geographic impact of Satoshi Okuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Okuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Okuno more than expected).

Fields of papers citing papers by Satoshi Okuno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Okuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Okuno. The network helps show where Satoshi Okuno may publish in the future.

Co-authorship network of co-authors of Satoshi Okuno

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Okuno. A scholar is included among the top collaborators of Satoshi Okuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Okuno. Satoshi Okuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Okuno, Satoshi, et al.. (2023). IL‐31 and IL‐31 receptor alpha in pemphigus: Contributors to more than just itch?. The Journal of Dermatology. 50(7). 927–930. 4 indexed citations
3.
Okuno, Satoshi, et al.. (2023). Study on Displaying Images to Prevent VR Sickness while Maintaining Rich-Presence. IEEJ Journal of Industry Applications. 13(1). 98–104.
4.
Hashimoto, Takashi, et al.. (2023). Pemphigoid nodularis associated with pembrolizumab in a lung cancer patient. European Journal of Dermatology. 33(1). 53–54.
7.
Tsuji, Takumi, et al.. (2015). Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. Allergology International. 65(2). 172–179. 7 indexed citations
8.
Ma, Huaiyu, Xiaoming Li, Zhijian Yang, et al.. (2010). High Antimetastatic Efficacy of MEN4901/T-0128, a Novel Camptothecin Carboxymethyldextran Conjugate. Journal of Surgical Research. 171(2). 684–690. 10 indexed citations
9.
Harada, Mitsunori, et al.. (2001). Carrier and dose effects on the pharmacokinetics of T-0128, a camptothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats. Journal of Controlled Release. 71(1). 71–86. 33 indexed citations
10.
Harada, Mitsunori, et al.. (2000). Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate. Journal of Controlled Release. 69(3). 399–412. 60 indexed citations
11.
Yano, Toshiro, et al.. (2000). Structure–activity relationships of carboxymethylpullulan-peptide-doxorubicin conjugates—systematic modification of peptide spacers. Bioorganic & Medicinal Chemistry Letters. 10(3). 227–230. 16 indexed citations
12.
Yamamoto, Keiji, et al.. (2000). Distribution Characteristics of Carboxymethylpullulan-Peptide-Doxorubicin Conjugates in Tumor-Bearing Rats: Different Sequence of Peptide Spacers and Doxorubicin Contents.. Biological and Pharmaceutical Bulletin. 23(5). 621–626. 24 indexed citations
13.
Harada, Mitsunori, Jun Imai, Satoshi Okuno, & Takehiko Suzuki. (2000). Macrophage-mediated activation of camptothecin analogue T-2513–carboxymethyl dextran conjugate (T-0128): possible cellular mechanism for antitumor activity. Journal of Controlled Release. 69(3). 389–397. 18 indexed citations
14.
Suzuki, Kokichi, et al.. (1999). Renal Drug Targeting Using a Vector “Alkylglycoside”. Journal of Pharmacology and Experimental Therapeutics. 288(1). 57–64. 34 indexed citations
15.
Suzuki, Kokichi, et al.. (1999). Renal Targeting of Arginine-Vasopressin by Modification with Carbohydrates at the Tyrosine Side Chain.. Biological and Pharmaceutical Bulletin. 22(10). 1094–1098. 10 indexed citations
16.
Yano, T., et al.. (1995). Synthesis of Carboxymethylpullulan-Peptide-Doxorubicin Conjugates and Their Properties.. Chemical and Pharmaceutical Bulletin. 43(11). 1931–1936. 34 indexed citations
17.
Irie, Kazuhiro, et al.. (1994). Tissue-Targeting Ability of Saccharide-Poly(L-Lysine) Conjugates.. Biological and Pharmaceutical Bulletin. 17(2). 275–282. 28 indexed citations
18.
Sugawara, Tamio, Hiroyuki Iwasawa, Takayoshi Yoshikawa, et al.. (1992). Synthesis of ω-(methoxycarbonyl)alkyl and 9-(methoxycarbonyl)-3,6-dioxanonyl glycopyranosides for the preparation of carbohydrate-protein conjugates. Carbohydrate Research. 230(1). 117–149. 7 indexed citations
19.
Okuno, Satoshi, et al.. (1988). Effect of the hydroxyl group of the p-hydroxyphenyl moiety of aspoxicillin, a semisynthetic penicillin, on its pharmacokinetic property.. The Journal of Antibiotics. 41(2). 239–246. 6 indexed citations
20.
Suyama, Takayuki, et al.. (1986). The dimerization reaction of N-silylated cyanamide derivatives.. NIPPON KAGAKU KAISHI. 1202–1205. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026